Microfluidic paper-based analytical devices (µPADs) have provided a breakthrough in portable and low-cost point-of-care diagnostics. Despite their significant scope, the complexity of fabrication and reliance on expensive and sophisticated tools, have limited their outreach and possibility of commercialization. Herein, we report for the first time, a facile method to fabricate µPADs using a commonly available laser printer which drastically reduces the cost and complexity of fabrication. Toner ink is used to pattern the µPADs by printing, without modifying any factory configuration of the laser printer. Hydrophobic barriers are created by heating the patterned paper which melts the toner ink, facilitating its wicking into the cross-section of the substrate. Further, we demonstrate the utilization of the fabricated device by performing two assays. The proposed technique provides a versatile platform for rapid prototyping of µPADs with significant prospect in both developed and resource constrained region.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536539 | PMC |
http://dx.doi.org/10.1038/s41598-019-44455-1 | DOI Listing |
Nanomaterials (Basel)
January 2025
Department of Physics and Engineering, Moldova State University, MD-2009 Chisinau, Moldova.
This article analyzes the prospects for the appearance of paper-based sensors on the sensor market. It is concluded that paper-based sensors are not a fantasy but a reality. It is shown that paper has properties that make it possible to develop a wide variety of paper-based sensors, such as SERS, colorimetric, fluorescent, conductometric, capacitive, fiber-optic, electrochemical, microfluidic, shape-deformation, microwave, and various physical sensors.
View Article and Find Full Text PDFBiosensors (Basel)
January 2025
CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Universidade Católica Portuguesa, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
Chronic Kidney Disease (CKD) is a disorder that affects over 10% of the global population, and that would benefit from innovative methodologies that would provide early detection. Since it has been reported that there are high levels of urease in CKD patients' saliva, this sample is a promising non-invasive alternative to blood for CKD detection and monitoring. This work introduces a novel 3D µPAD for quantifying urease activity in saliva in a range of 0.
View Article and Find Full Text PDFBiosensors (Basel)
January 2025
Department of Biomedical Laboratory Science, Daegu Health College, Chang-ui Building, 15 Yeongsong-ro, Buk-gu, Daegu 41453, Republic of Korea.
Point-of-care (POC) use is one of the essential goals of biosensing platforms. Because the increasing demand for testing cannot be met by a centralized laboratory-based strategy, rapid and frequent testing at the right time and place will be key to increasing health and safety. To date, however, there are still difficulties in developing a simple and affordable, as well as sensitive and effective, platform that enables POC use.
View Article and Find Full Text PDFACS Appl Bio Mater
January 2025
Division of Applied Chemistry, Faculty of Engineering, Hokkaido University, Kita 13 Nishi 8, Kita-ku, Sapporo 060-8628, Japan.
Ensuring detection performance and shelf life is crucial for analytical devices. Advances in materials and reaction mechanisms have improved detection performance, yet extending the operational lifetime of microfluidic paper-based analytical devices (μPADs)─especially those reliant on sensitive enzymes─remains a challenge. Here, we present an alternative to air-drying and lyophilization: loading enzymes suspended in 2-propanol (iPrOH).
View Article and Find Full Text PDFSmall
January 2025
Department of Chemistry, Fudan University, Shanghai, 200438, China.
Rapid and sensitive detection of Epstein-Barr virus cell-free DNA (EBV cfDNA) is crucial for early diagnosis and monitoring of nasopharyngeal carcinoma (NPC), but accessibility to screening is limited by complicated and costly conventional DNA isolation and purification approaches. Here, a fully integrated ion concentration polarization (ICP)-enriched and nanozyme-catalyzed lateral flow assay (ICP-cLFA) is developed, enabling total analysis of EBV cfDNA in whole blood samples, with DNA isolation, pre-concentration, and amplification performed on a microfluidic chip, consequently providing the signal readout within 75 min. Specifically, ICP preconcentration and amplification steps, together with target recognition catalyzed by a platinum-decorated mesoporous gold nanosphere (MGNS@Pt) nanozyme, result in an ultralow detection limit of 4 aM in standard cfDNA samples and 100 aM in whole blood from NPC-bearing rats.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!